American Society of Hematology

SHERPA: Blue

People

  1. Maclachlan
    Maclachlan
  2. Usmani
    Usmani
  3. Lesokhin
    Lesokhin
  4. Hultcrantz
    Hultcrantz
  5. Korde
    Korde
  6. Shah
    Shah
  7. Landau
    Landau
  8. Mailankody
    Mailankody
  9. Giralt
    Giralt
  10. Tan
    Tan

Groups

  1. GME, Medicine (77)
  2. Graduate Medical Education (77)
  3. Department of Medicine (67)
  4. Center for Hematologic Malignancies (65)
  5. Hematologic Malignancies, Division of (65)
  6. Myeloma (65)
  7. Hematologic Malignancies Research (62)
  8. Sloan Kettering Institute Postdocs (55)
  9. Hematology-Oncology Fellows (52)
  10. Survivorship Research (51)
Search Within
  1. "Kylee Maclachlan"
Formats
  1. Meeting Abstract (67)
  2. Journal Article (9)
  3. Research Letter (1)
Groups
  1. GME, Medicine (77)
  2. Graduate Medical Education (77)
  3. Department of Medicine (67)
  4. Center for Hematologic Malignancies (65)
  5. Hematologic Malignancies, Division of (65)
  6. Myeloma (65)

More Groups

People
  1. Kylee Maclachlan (77)
  2. Saad Usmani (65)
  3. Alexander Lesokhin (56)
  4. Malin Hultcrantz (51)
  5. Neha Korde (47)
  6. Urvi Shah (47)

More People

Years
  1. 2025 (2)
  2. 2024 (26)
  3. 2023 (23)
  4. 2022 (15)
  5. 2021 (5)
  6. 2020 (6)
Publications
  1. Blood (70)
  2. Blood Advances (7)

Results (77)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
    Journal Article

    Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin, nirogacestat and pomalidomide for patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; Hashmi, H.; Maclachlan, K. H.; Rajeeve, S.; Shah, U. A.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mutationally enriched regions of the non-coding genome harbor functionally impactful mutations that dysregulate key genes involved in multiple myeloma pathogenesis
    Meeting Abstract

    Blaney, P.; Maclachlan, K. H.; Papadimitriou, M.; Mikulasova, A.; Gagler, D. C.; Braunstein, M. J.; Lahoud, O. B.; Kaminetzky, D.; Wang, Y.; Liu, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Replication stress induces hyper-APOBEC mutagenesis in multiple myeloma
    Meeting Abstract

    Tauro, M.; Panahi, A.; Ziccheddu, B.; Poos, A. M.; Alaoui, A. Y.; Magaletti, D.; Meads, M. B.; Maclachlan, K. H.; Raab, M. S.; Morgan, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those having European ancestry
    Meeting Abstract

    Maclachlan, K. H.; Papadimitriou, M.; Blaney, P.; Shekarkhand, T.; Chu, T. R.; Poos, A. M.; Brown, E.; Hoering, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; Garcés, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save